You searched for Antibody candidate - Page 64 of 69

News and Trends 26 Jan 2016

Gilead On Board, But Still No Easy Sailing for Galapagos with Phase IIa Failure

…We speculate. However, Galapagos have also just released phase IIa trials for another candidate (GLPG1205) in Ulcerative Colitis. Whilst good safety and tolerability profiles for this small-molecule candidate were found,…

January 26, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 18 Jul 2016

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

…most CAR-T Biotechs share the same target? UPDATE (article originally published on 8/7/2016): the FDA has allowed Juno Therapeutics to resume its CAR-T trial with JCAR015, the Biotech’s leading candidate….

July 18, 2016 - 5 minutesmins - By Denise Neves Gameiro

Best in Biotech 22 May 2023

Five recent advancements in arthritis research over the past year

…Month in May, here are five recent advancements in arthritis research over the past year. Acelyrin’s drug candidate advances in phase 2 clinical trials for psoriatic arthritis treatment For the…

May 22, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 15 Oct 2019

German Cancer Virotherapy Biotech Launches with €12M Series A

…the arenavirus candidates that Abalos is developing will rely on the patient’s immune system to target cancer cells. According to the company, replication of its arenavirus candidates in the targeted…

October 15, 2019 - 2 minutesmins - By Helen Albert

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

…antibody BI-1206, in non-Hodgkin’s lymphoma (NHL) and the anti-TNFR2 antibody BI-1808 in cutaneous T-cell lymphoma (CTCL). “We are delighted to conclude this agreement with the widely respected patient organization Leukemia…

January 18, 2023 - 4 minutesmins - By Jim Cornall

Novartis Cardiovascular Canakinumab Phase III

News and Trends 22 Jun 2017

Novartis Scores Major Phase III Win with New Cardiovascular Drug

…in one of the largest and longest-running Phase III trials in the company’s history. Canakinumab is a fully human monoclonal antibody that inhibits IL-1ß, a key cytokine in the inflammatory…

June 22, 2017 - 2 minutesmins - By Melanie De Almeida

Best in Biotech 4 Nov 2019

Top 10 Biotech Companies Leaving a Mark in Munich

…biotech industry. MorphoSys Morphosys is one of just a few biotech companies in Europe valued at over €1Bn. Founded in 1992, the company specializes in the development of antibody treatments…

November 4, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 31 Oct 2016

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

…improvement in physical function of patient joints. There is a strong competition for antibody research into chronic auto-immune diseases such as Rheumatoid. A few Biotech giants are extra anxious to…

October 31, 2016 - 3 minutesmins - By Dani Bancroft

In Depth 2 Jan 2018

The Labiotech Dictionary of Important Biotech Terms

…up to the immune system for destruction. The structure of an antibody, which allows it to bind dangerous pathogens, fight infection and stimulate an immune response. Some of Europe’s best…

January 2, 2018 - 14 minutesmins - By Alex Dale

News and Trends 16 Sep 2022

Marengo advancing its lead TCR activator into clinic after FDA clearance

…a bi-functional fusion antibody that deploys a mechanism of T cell activation that has demonstrated potent single agent activity in PD-1 refractory settings in preclinical studies. Marengo Therapeutics plans to…

September 16, 2022 - 2 minutesmins - By Liza Laws

adc therapeutics genomics sophia genetics blood cancer

News and Trends 6 Aug 2019

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

…who will respond best to the drug. No financial details of the deal were disclosed. ADC Therapeutics’ drug is an antibody that is chemically joined to a molecule that kills…

August 6, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 27 Jan 2023

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

…beta (Aβ) protofibril antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia) with confirmed amyloid pathology, for review following…

January 27, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Gilead On Board, But Still No Easy Sailing for Galapagos with Phase IIa Failure

UPDATED: Storm on the CAR-T field – 3 patients die in Phase II Study

Five recent advancements in arthritis research over the past year

German Cancer Virotherapy Biotech Launches with €12M Series A

BioInvent receives funding for blood cancer treatments

Novartis Scores Major Phase III Win with New Cardiovascular Drug

Top 10 Biotech Companies Leaving a Mark in Munich

UPDATE: FDA rejects Sanofi’s promising Rheumatoid Arthritis Drug

The Labiotech Dictionary of Important Biotech Terms

Marengo advancing its lead TCR activator into clinic after FDA clearance

ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!